# Novel CRISPR therapy is poised to gain first FDA approval to alter genes inside the body

Source: [nature.com](https://www.nature.com/articles/d41586-026-03705-9) · 2026-11-12 · Life
Page: https://themorning.science/story/novel-crispr-therapy-is-poised-to-gain-first-fda-approval-to-alter-genes-inside-d4ec44a48bc9cf60
Kind: other · Impact: medium

## In brief

- A novel CRISPR therapy is poised to gain its first FDA approval for altering genes inside the body.
- Earlier CRISPR treatments require removing a participant's cells, a complex and costly approach.

## Why it matters

An in-body approach would avoid removing and reinfusing a patient's cells, which the source describes as complex and costly in earlier CRISPR treatments.

## Coverage

- [Novel CRISPR therapy is poised to gain first FDA approval to alter genes inside the body](https://www.nature.com/articles/d41586-026-03705-9) — nature.com, 2026-11-12

Tags: crispr, gene-editing, gene-therapy, fda

---

Brief generated by AI (claude-haiku-5-5) from the reporting listed under Coverage. Headlines belong to their publishers. The Morning Science – https://themorning.science